Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Gaobo Hong

Dalian University of Technology

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 18, 2026 · JOURNAL ARTICLE

Combining Type I&II Photosensitizer With Hypoxia‐Activated Prodrug Enables Oxygen‐Unrestricted Synergistic Photocatalytic Therapy

Small

Preclinical mechanistic study demonstrating a novel nanoparticle design strategy in vitro and in vivo tumor models, without clinical efficacy data or direct comparison to established standards.

Hypothesis-GeneratingGaobo Hong Yingnan Wu Hanhan Lu

Study details

DesignPreclinical in vitro and in vivo proof-of-c…

InterventionDT@TH302 nanoparticles: dual-mechanism phot…

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support